Pacira BioSciences, Inc.
PCRX · NASDAQ · USD
$36.39
+11.19 44.40%todayNot financial advice.
- Open
- 36.33
- Day range
- 36.27 - 36.46
- 52-week range
- 18.80 - 36.46
- Volume
- 28.9M
- Market cap
- 1.45B
- P/E ratio
- 104.87
- EPS
- 0.35
- Dividend yield
- 0.00%
- Beta
- -0.01
Performance
W
+45.27%
1M
+40.07%
3M
+42.43%
6M
+52.13%
YTD
+39.59%
Y
+53.74%
5Y
−25.34%
All
+419.86%
In the news
Oct 8
Pacira and Haemonetics Shares Surge on Acquisition Deal and Expanded Partnership
Pacira BioSciences surges on a $1.65 billion buyout by Viatris, while Haemonetics climbs after expanding its plasma collection partnership.
Mergers
Oct 8
Viatris to Acquire Pacira BioSciences for $1.65 Billion to Expand Non-Opioid Pain Portfolio
Viatris is buying Pacira BioSciences for $1.65 billion to expand its non-opioid pain treatment portfolio and boost its innovative medicines business.
Mergers
Oct 8
Viatris to Acquire Pacira BioSciences in All-Cash Deal Valued at $36.50 Per Share
Pacira BioSciences will be acquired by Viatris in an all-cash deal worth $36.50 per share to provide immediate cash value to shareholders.
Mergers
Oct 8
Viatris to Acquire Pacira BioSciences in $1.65 Billion Cash Deal
Viatris has agreed to buy Pacira BioSciences for $36.50 per share in cash in a deal valued at $1.65 billion, expected to close by the end of 2026.
Mergers
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-PCRX" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Pacira BioSciences, Inc. (PCRX) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-PCRX">PCRX stock price</a> by FreeTheAI Stocks</p>